Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBT for insomnia (CBT-I) is considered the first-line treatment for insomnia (557) and outperforms pharmacological interventions, in particular with respect to maintenance of therapeutic effects at long-term follow-up (270, 513).”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [557]
Citations
Cites
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Self-citationProstaglandins: Their Disappearance from and Release into the Circulation
FERREIRA, S. H., & VANE, J. R. (1967) · Nature · doi:10.1038/216868a0 · Cited by 892
Self-citationRelease of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
PIPER, P. J., & VANE, J. R. (1969) · Nature · doi:10.1038/223029a0 · Cited by 880
Self-citationA SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE
VANE, J. R. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00146.x · Cited by 772
Self-citationTHE PROSTAGLANDINS: A FAMILY OF BIOLOGICALLY ACTIVE LIPIDS
BERGSTRÖM, S., CARLSON, L. A., & WEEKS, J. R. (1968) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07108-x · Cited by 634
Prostaglandins released by the Spleen
Gilmore, N. J., Vane, J. R., & Wyllie, J. H. (1968) · Nature · doi:10.1038/2181135a0 · Cited by 548
Self-citationProstaglandins and related factors: XIX. Thin-layer chromatography of prostaglandins
Gréen, K., & Samuelsson, B. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40270-6 · Cited by 476
Cutaneous reactions to intradermal prostaglandins
Crunkhorn, P., & Willis, A. L. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb09934.x · Cited by 348
The enzymic conversion of all‐cis 8,11,14‐eicosatrienoic acid into prostaglandin E1
Nugteren, D. H., Beerthuis, R. K., & van Dorp, D. A. (1966) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19660850412 · Cited by 339
Research works printed but not linked: 11
- Jacques, R., Helv. Physiol. Pharmacol. Acta, 23, 156 (1965).
- Berry, P. A., thesis, Council for National Academic Awards, London, 91 (1966).
- Vargaftig, B. B., and Dao, N., Pharmacology (in the press).
- Piper, P. J., and Vane, J. R., in Prostaglandins (edit. by Ramwell, P., and Shaw, J.) (NY Acad. Sci., in the press, 1971).
- Willis, A. L., Brit. J. Pharmacol., 40, 583P (1970).
- Milton, A. S., and Wendlandt, S. J., J. Physiol., 207, 76P (1970).
- Feldberg, W., and Saxena, P. N., J. Physiol. (in the press, 1971).
- Willis, A. L., in Prostaglandins, Peptides and Amines (edit. by Mantegazza, P., and Horton, E. W.), 31 (Academic Press, London, 1969).
- Collier, H. O. J., Nature (in the press).
- Goodman, L. S., and Gilman, A., The Pharmacological Basis ofTherapeutics, fourth ed. (Collier-Macmillan, London, 1970).
- Hucker, H. B., Zacchei, A. G., Cox, S. V., Brodie, D. A., and Cantwell, N. H. R., J. Pharmac. Exp. Therap., 153, 237 (1966).
Cited by
Items 201–300 of 1,039
Prostacyclin is a circulating hormone
MONCADA, S., KORBUT, R., BUNTING, S., & VANE, J. R. (1978) · Nature · doi:10.1038/273767a0 · Cited by 379
Self-citationAugmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Schönbeck, U., Sukhova, G. K., Graber, P., Coulter, S., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65230-3 · Cited by 379
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809153191106 · Cited by 379
The role of lipids in platelet function: with particular reference to the arachidonic acid pathway.
Marcus, A. J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40694-7 · Cited by 379
Piazza, G. A., Rahm, A. K., Finn, T. S., Fryer, B., Li, H., Stoumen, A. L., Pamukcu, R., & Ahnen, D. J. (1997) · PubMed · Cited by 375
Collier, H. O. J., & Roy, A. C. (1974) · Nature · doi:10.1038/248024a0 · Cited by 374
The Essentiality of Arachidonic Acid in Infant Development
Hadley, K., Ryan, A., Forsyth, S., Gautier, S., & Salem, N. (2016) · Nutrients · doi:10.3390/nu8040216 · Cited by 373
Anti-inflammatory effects of aspirin and sodium salicylate
Amann, R., & Peskar, B. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01828-9 · Cited by 372
Nonsteroidal anti-inflammatory drug gastropathy
Hawkey, C. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.9561 · Cited by 371
Cyclooxygenase-2: Regulation and relevance in inflammation
Mitchell, J. A., Larkin, S., & Williams, T. J. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00212-x · Cited by 371
Leese, P. T., Hubbard, R. C., Karim, A., Isakson, P. C., Yu, S. S., & Geis, G. S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008766 · Cited by 371
Hawkey, C. J., & Rampton, D. S. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90225-2 · Cited by 368
Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis
Schafer, A. I. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04050.x · Cited by 367
Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
Vonkeman, H. E., & van de Laar, M. A. F. J. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.001 · Cited by 365
In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives
Achar, K. C. S., Hosamani, K. M., & Seetharamareddy, H. R. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.01.029 · Cited by 364
Kaplan, A. P. (1979) · Cellular, Molecular, and Clinical Aspects of Allergic Disorders · doi:10.1007/978-1-4684-0988-8_8 · Cited by 363
Milton, A. S., & Wendlandt, S. (1971) · The Journal of Physiology · doi:10.1113/jphysiol.1971.sp009620 · Cited by 359
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., & Salvemini, D. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.1 · Cited by 357
Coller, B. S., & Shattil, S. J. (2008) · Blood · doi:10.1182/blood-2008-06-077891 · Cited by 352
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
McCoy, J. M., Wicks, J. R., & Audoly, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15528 · Cited by 352
Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?
Botting, R. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317520 · Cited by 350
“Experiments were performed to confirm the report of Flower and Vane [75] that brain COX is more sensitive to inhibition by acetaminophen than spleen COX.”
BackgroundRelease of gelatinase A during platelet activation mediates aggregation
Sawicki, G., Salas, E., Murat, J., Miszta-Lane, H., & Radomski, M. W. (1997) · Nature · doi:10.1038/386616a0 · Cited by 348
PROSTAGLANDIN E2, PROSTAGLANDIN I2 AND THE VASCULAR CHANGES OF INFLAMMATION
WILLIAMS, T. J. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb07860.x · Cited by 344
Fever and hypothermia in systemic inflammation: recent discoveries and revisions
Romanovsky, A. (2005) · Frontiers in Bioscience · doi:10.2741/1690 · Cited by 344
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis
Szczeklik, A., Gryglewski, R. J., & Czerniawska-Mysik, G. (1977) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(77)90106-3 · Cited by 344
Topical and Peripherally Acting Analgesics
Sawynok, J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.1 · Cited by 344
An overview of PROTACs: a promising drug discovery paradigm
Liu, Z., Hu, M., Yang, Y., Du, C., Zhou, H., Liu, C., Chen, Y., Fan, L., Ma, H., Gong, Y., et al. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00112-0 · Cited by 344
Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents
Gaba, M., Singh, S., & Mohan, C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.030 · Cited by 344
Oral versus Topical NSAIDs in Rheumatic Diseases: A Comparison
Heyneman, C. A., Lawless-Liday, C., & Wall, G. C. (2000) · Drugs · doi:10.2165/00003495-200060030-00004 · Cited by 341
Orczyk, G. P., & Behrman, H. R. (1972) · Prostaglandins · doi:10.1016/0090-6980(72)90061-5 · Cited by 341
Resolution of inflammation: An organizing principle in biology and medicine
Panigrahy, D., Gilligan, M. M., Serhan, C. N., & Kashfi, K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107879 · Cited by 340
Naturally occurring antinociceptive substances from plants
Calixto, J. B., Beirith, A., Ferreira, J., Santos, A. R. S., Filho, V. C., & Yunes, R. A. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200009)14:6<401::aid-ptr762>3.0.co;2-h · Cited by 339
Herrmann, W. A., Öfele, K., v. Preysing, D., & Schneider, S. K. (2003) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2003.07.028 · Cited by 339
PROSTAGLANDINS AND OTHER EICOSANOIDS IN INSECTS: Biological Significance
STANLEY, D. W. (2005) · Annual Review of Entomology · doi:10.1146/annurev.ento.51.110104.151021 · Cited by 338
Gryglewski, R. J., Panczenko, B., Korbut, R., Grodzińska, L., & Ocetkiewicz, A. (1975) · Prostaglandins · doi:10.1016/s0090-6980(75)80087-6 · Cited by 336
Mechanisms of CNS response to systemic immune challenge: the febrile response
Elmquist, J. K., Scammell, H. E., & Saper, C. B. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01138-7 · Cited by 334
Interleukin‐8 as a mediator of sympathetic pain
Cunha, F. Q., Lorenzetti, B. B., Poole, S., & Ferreira, S. H. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12502.x · Cited by 333
Evans, J. F., Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., & Taketo, M. M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02780.x · Cited by 333
Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage
Schoen, R. T., & Vender, R. J. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90344-6 · Cited by 332
Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono, T., Tofilon, P. J., Bruner, J. M., Owolabi, O., & Lang, F. F. (2001) · PubMed · Cited by 332
Intracellular phospholipases A
van den BOSCH, H. (1980) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(80)90008-8 · Cited by 332
Advances in cobalt complexes as anticancer agents
Munteanu, C. R., & Suntharalingam, K. (2015) · Dalton Transactions · doi:10.1039/c5dt02101d · Cited by 330
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 330
Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammation
Beiche, F., Scheuerer, S., Brune, K., Geisslinger, G., & Goppelt-Struebe, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00604-7 · Cited by 329
The aspirin story – from willow to wonder drug
Desborough, M. J. R., & Keeling, D. M. (2017) · British Journal of Haematology · doi:10.1111/bjh.14520 · Cited by 328
Antipyretics: mechanisms of action and clinical use in fever suppression
Aronoff, D. M., & Neilson, E. G. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00834-8 · Cited by 326
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration
Sutherland, B. A., Rahman, R. M. A., & Appleton, I. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.10.005 · Cited by 325
Gill, J. R., Fro¨lich, J. C., Bowden, R. E., Taylor, A. A., Keiser, H. R., Seyberth, H. W., Oates, J. A., & Bartter, F. C. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90029-2 · Cited by 324
Mediators produced by the endothelial cell.
Gryglewski, R. J., Botting, R. M., & Vane, J. R. (1988) · Hypertension · doi:10.1161/01.hyp.12.6.530 · Cited by 324
Self-citationAspirin-induced asthma: Advances in pathogenesis and management
Szczeklik, A., & Stevenson, D. D. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70106-5 · Cited by 323
Ethnopharmacologic investigation of ginger (Zingiber officinale)
Mascolo, N., Jain, R., Jain, S. C., & Capasso, F. (1989) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(89)90085-8 · Cited by 323
EHRICH, E., DALLOB, A., DELEPELEIRE, I., VANHECKEN, A., RIENDEAU, D., YUAN, W., PORRAS, A., WITTREICH, J., SEIBOLD, J., & DESCHEPPER, P. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70113-x · Cited by 322
Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans
Morris, T., Stables, M., Hobbs, A., de Souza, P., Colville-Nash, P., Warner, T., Newson, J., Bellingan, G., & Gilroy, D. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900477 · Cited by 322
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
Mitchell, J. A., & Warner, T. D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702897 · Cited by 321
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
McCoy, J. M., Wicks, J. R., & Audoly, L. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215528 · Cited by 320
Clinical Pharmacokinetics of the Salicylates
Needs, C. J., & Brooks, P. M. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510020-00004 · Cited by 320
Blackwell, G. J., Flower, R. J., Nijkamp, F. P., & Vane, J. R. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb07009.x · Cited by 320
Self-citationSalicylate Induces Tinnitus through Activation of Cochlear NMDA Receptors
Guitton, M. J., Caston, J., Ruel, J., Johnson, R. M., Pujol, R., & Puel, J.-L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03944.2003 · Cited by 319
Multi-target approach for natural products in inflammation
Koeberle, A., & Werz, O. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.006 · Cited by 317
Salicylic acid in the machinery of hypersensitive cell death and disease resistance
Alvarez, M. E. (2000) · Plant Molecular Biology · doi:10.1023/a:1026561029533 · Cited by 316
Hawkey, C. J. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0236 · Cited by 316
Awouters, F., Niemegeers, C. J. E., Lenaerts, F. M., & Janssen, P. A. J. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13150.x · Cited by 315
The first 3500 years of aspirin history from its roots – A concise summary
Montinari, M. R., Minelli, S., & De Caterina, R. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.10.008 · Cited by 315
COX-2: A Target for Colon Cancer Prevention
Marnett, L. J., & DuBois, R. N. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082301.164620 · Cited by 313
Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids
Ferrándiz, M. L., & Alcaraz, M. J. (1991) · Agents and Actions · doi:10.1007/bf01980887 · Cited by 313
Role of prostaglandin endoperoxide PGG2 in inflammatory processes
Kuehl, F. A., Humes, J. L., Egan, R. W., Ham, E. A., Beveridge, G. C., & Arman, C. G. V. (1977) · Nature · doi:10.1038/265170a0 · Cited by 313
Resistance of germfree rats to indomethacin-induced intestinal lesions
Robert, A., & Asano, T. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90178-2 · Cited by 312
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312
Self-citationSelective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis
Reddy, C. M., Bhat, V. B., Kiranmai, G., Reddy, M. N., Reddanna, P., & Madyastha, K. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3725 · Cited by 310
LEES, P., LANDONI, M. F., Giraudel, J., & TOUTAIN, P. L. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00617.x · Cited by 310
Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase
Schwartzman, M., Ferreri, N. R., Carroll, M. A., Songu-Mize, E., & McGiff, J. C. (1985) · Nature · doi:10.1038/314620a0 · Cited by 310
Takada, Y., Bhardwaj, A., Potdar, P., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 310
NSAIDs and Cancer Prevention: Targets Downstream of COX-2
Cha, Y. I., & DuBois, R. N. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131253 · Cited by 308
Mitchell, J. A., Belvisi, M. G., Akarasereenont, P., Robbins, R. A., Kwon, O. ‐., Croxtall, J. J., Barnes, P. J., & Vane, J. R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17093.x · Cited by 307
Self-citationMitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs
Xie, W., Robertson, D. L., & Simmons, D. L. (1992) · Drug Development Research · doi:10.1002/ddr.430250402 · Cited by 306
Trends in the use of aspirin and nonsteroidal anti‐inflammatory drugs in the general U.S. population
Zhou, Y., Boudreau, D. M., & Freedman, A. N. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3463 · Cited by 304
Fachini-Queiroz, F. C., Kummer, R., Estevão-Silva, C. F., Carvalho, M. D. D. B., Cunha, J. M., Grespan, R., Bersani-Amado, C. A., & Cuman, R. K. N. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/657026 · Cited by 304
Hawkey, C. J., Kahan, A., Steinbruck, K., Alegre, C., Baumelou, E., Bégaud, B., Dequeker, J., Isomäki, H. A., Littlejohn, G. O., Mau, J., et al. (1998) · Rheumatology · doi:10.1093/rheumatology/37.9.937 · Cited by 304
Regulation of inflammation in cancer by eicosanoids
Greene, E. R., Huang, S., Serhan, C. N., & Panigrahy, D. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.08.004 · Cited by 303
Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?
Warner, T. D., & Mitchell, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222543099 · Cited by 302
The Spinal Phospholipase-Cyclooxygenase-Prostanoid Cascade in Nociceptive Processing
Svensson, C. I., & Yaksh, T. L. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.092401.143905 · Cited by 302
Trivedi, M. K., Branton, A., & Shettigar, H. (2015) · Natural Products Chemistry & Research · doi:10.4172/2329-6836.1000186 · Cited by 302
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
Xu, X.-M., Sansores-Garcia, L., Chen, X.-M., Matijevic-Aleksic, N., Du, M., & Wu, K. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5292 · Cited by 301
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
Crofford, L. J., Lipsky, P. E., Brooks, P., Abramson, S. B., Simon, L. S., & Van De Putte, L. B. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<4::aid-anr2>3.0.co;2-v · Cited by 296
Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia
Fosslien, E. (2000) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360091174286 · Cited by 296
Prostaglandins and the mechanism of analgesia produced by aspirin‐like drugs
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1997) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1997.tb06823.x · Cited by 296
Self-citationProstaglandins and the mechanism of analgesia produced by aspirin‐like drugs
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08270.x · Cited by 296
Self-citationDesign, synthesis and antiinflammatory activity of some 1,3,4-oxadiazole derivatives
Omar, F. A., Mahfouz, N., & Rahman, M. A. (1996) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(96)83976-6 · Cited by 295
Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis
Trappe, T. A., White, F., Lambert, C. P., Cesar, D., Hellerstein, M., & Evans, W. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00352.2001 · Cited by 293
“1), which then reduces metabolites produced by this enzyme, such as prostaglandins, that are at least partially responsible for inflammation and algesia (14, 35, 36).”
BackgroundPharmacodynamic profile of prostacyclin
Vane, J. R., & Botting, R. M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80377-4 · Cited by 292
Self-citationNatural anti-inflammatory agents for pain relief
Bost, J., Maroon, A., & Maroon, J. (2010) · Surgical Neurology International · doi:10.4103/2152-7806.73804 · Cited by 292
PROSTAGLANDINS AND BREAST CANCER
Bennett, A., Mcdonald, A. M., Stamford, I. F., Charlier, E. M., Simpson, J. S., & Zebro, T. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92496-5 · Cited by 292
Ciobica, A., Balmus, I., Trifan, A., & Stanciu, C. (2016) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.173753 · Cited by 292
Armstrong, D. T., & Grinwich, D. L. (1972) · Prostaglandins · doi:10.1016/0090-6980(72)90062-7 · Cited by 291
Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer
Levy, G. N. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.4.9068612 · Cited by 290
Rome, L. H., & Lands, W. E. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.4863 · Cited by 290
Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.11.1095 · Cited by 290
Masunaga, R., Kohno, H., Dhar, D. K., Ohno, S., Shibakita, M., Kinugasa, S., Yoshimura, H., Tachibana, M., Kubota, H., & Nagasue, N. (2000) · PubMed · doi:10.11501/3179825 · Cited by 290
Antagonism of Cholera Enterotoxin by Anti-inflammatory Agents in the Rat
Jacoby, H. I., & MARSHALL, C. H. (1972) · Nature · doi:10.1038/235163a0 · Cited by 290
Role of Surface-Active Phospholipids in Gastric Cytoprotection
Lichtenberger, L. M., Graziani, L. A., Dial, E. J., Butler, B. D., & Hills, B. A. (1983) · Science · doi:10.1126/science.6828859 · Cited by 289
Metadata
- Authors
- VANE, J. R.
- Affiliations
- Royal College of Surgeons of England (GB)
- Corresponding author
- VANE, J. R.
- Venue
- Nature New Biology
- Published
- 1971-06
- Volume
- 231
- Issue
- 25
- Pages
- 232-235
- ISSN
- 0090-0028 (ISSN-L)
- 2058-1092
- OpenAlex
- W2008574207
- Cited by
- 8,605
- References
- 26
- Citations by year
- 2026: 51 · 2025: 72 · 2024: 86 · 2023: 106 · 2022: 117 · 2021: 121 · 2020: 118 · 2019: 114 · 2018: 123 · 2017: 150 · 2016: 144 · 2015: 154 · 2014: 154 · 2013: 162 · 2012: 190
- FWCI
- 183.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature New Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- aspirin, salicylates, prostaglandin synthesis inhibition, mechanism of action, guinea pig lung, anti-inflammatory agents
- MeSH terms
- Animals, Arachidonic Acids, Aspirin, Biological Assay, Chromatography, Thin Layer, Colon, Guinea Pigs, Indomethacin, Lung, Prostaglandins, Salicylates, Stomach, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.